Hu YL, Pan J, He YZ, Luo XH, Du WS. Significance of serum levels of pro-atrial natriuretic peptide in patients with liver diseases.
Shijie Huaren Xiaohua Zazhi 2012;
20:2293-2295. [DOI:
10.11569/wcjd.v20.i24.2293]
[Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 02/06/2023] Open
Abstract
AIM: To evaluate the diagnostic significance of serum levels of pro-atrial natriuretic peptide (pro-ANP) in patients with liver diseases.
METHODS: Serum samples collected from 32 hospitalized patients with abnormal liver function test results (including 13 patients with cirrhosis, 12 patients with hepatocellular carcinoma, 3 patients with drug-induced hepatitis, and 4 patients with chronic severe hepatitis B) and 20 healthy adults were used in this study. The levels of serum pro-ANP were detected.
RESULTS: Compared to healthy adults, serum levels of pro-ANP were significantly higher in patients with cirrhosis, hepatocellular carcinoma, drug-induced hepatitis, and chronic severe hepatitis B (t = 8.970, 9.088, 3.826, 8.240, all P < 0.001). Serum levels of pro-ANP were also significantly higher in patients with chronic severe hepatitis B than in those with cirrhosis, hepatocellular carcinoma, drug-induced hepatitis, but showed no significant differences among the other three groups of patients.
CONCLUSION: Increased serum pro-ANP levels have a diagnostic value in patients with various liver diseases.
Collapse